tiprankstipranks
Immunovia AB (IMMVF)
OTHER OTC:IMMVF
US Market

Immunovia AB (IMMVF) Income Statement

Compare
44 Followers

Immunovia AB Income Statement

Last quarter (Q4 2025), Immunovia AB's total revenue was kr354.00K, a decrease of -22.20% from the same quarter last year. In Q4, Immunovia AB's net income was kr-17.33M. See Immunovia AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 685.00Kkr 931.00Kkr 1.57Mkr 1.15Mkr 844.00K
Gross Profit
kr -79.50Mkr 931.00Kkr -5.11Mkr -3.07Mkr 15.81M
Operating Expenses
kr 0.00kr 110.34Mkr 291.35Mkr 188.14Mkr 182.55M
Depreciation and Amortization
kr 2.33Mkr 13.42Mkr 141.72Mkr 24.91Mkr 19.06M
EBITDA
kr -77.18Mkr -61.27Mkr -166.56Mkr -141.58Mkr -135.47M
Operating Income
kr -79.50Mkr -109.41Mkr -296.46Mkr -191.15Mkr -166.74M
Other Income/Expenses
kr -66.41Mkr 32.87Mkr -12.98Mkr 23.06Mkr 10.66M
Pretax Income
kr -145.91Mkr -76.54Mkr -309.44Mkr -168.09Mkr -155.97M
Net Income
kr -145.91Mkr -76.54Mkr -309.44Mkr -145.03Mkr -157.40M
Per Share Metrics
Basic EPS
kr -0.42kr -0.93kr -7.95kr -5.95kr -6.45
Diluted EPS
kr -0.42kr -0.93kr -7.95kr -5.95kr -6.45
Weighted Average Shares Outstanding
344.32M 82.61M 38.93M 24.39M 24.39M
Weighted Average Shares Outstanding (Diluted)
344.32M 82.61M 38.93M 24.39M 24.39M
Currency in SEK

Immunovia AB Earnings and Revenue History